Biointron introduces RushData platform for AI-driven antibody discovery
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and ML.
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and ML.
Source: Pharmaceutical Technology